Zoetis (ZTS) Non Operating Income (2012 - 2026)
Zoetis (ZTS) reported Non Operating Income of $20.0 million for Q1 2026, up 33.33% year-over-year from $15.0 million in Q1 2025, and up 122.22% quarter-over-quarter from $9.0 million in Q4 2025.
Zoetis (ZTS) Non Operating Income (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Non Operating Income data on file, last reported at $20.0 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at $20.0 million, up 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.0 million (up 46.15% YoY), and the FY2025 annual result was $36.0 million, up 89.47% from the prior year.
- Non Operating Income grew to $20.0 million in Q1 2026 per ZTS's latest filing, from $9.0 million in the prior quarter.
- Over five years, Non Operating Income peaked at $104.0 million in Q2 2023 and troughed at -$34.0 million in Q4 2022.
- A 5-year average of $11.2 million and a median of $8.0 million in 2023 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 5300.0% in 2023 and fell as far as 300.0% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$34.0 million in 2022, then soared by 123.53% to $8.0 million in 2023, then surged by 150.0% to $20.0 million in 2024, then plunged by 55.0% to $9.0 million in 2025, then surged by 122.22% to $20.0 million in 2026.
- Business Quant data shows ZTS's Non Operating Income at $20.0 million in Q1 2026, $9.0 million in Q4 2025, and $13.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | -4.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.00 Mn |
| Dec 31, 2025 | 9.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | -25.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Sep 30, 2023 | -6.00 Mn |
| Jun 30, 2023 | 104.00 Mn |
| Mar 31, 2023 | 53.00 Mn |
| Dec 31, 2022 | -34.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | -2.00 Mn |
| Mar 31, 2022 | -7.00 Mn |
| Dec 31, 2021 | -32.00 Mn |
| Sep 30, 2021 | -4.00 Mn |
| Jun 30, 2021 | -10.00 Mn |